For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole ...

On the same day North Carolina hospitals reported a record number of COVID-19 patients in intensive care units across the state, Gov. Roy Cooper signaled he will take action expanding access to a ...

Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that ...

While doctors have stressed the importance of COVID-19 vaccinations, there are also coronavirus treatments helping sick patients stay out of the hospital. Monoclonal antibody therapy is gaining ...

The exact mechanism responsible for infusion-related reactions (IRRs) after monoclonal antibody (mAb) therapy is unclear. It is also unknown before treatment which patient will develop IRRs. The ...

Autoimmune disorders occur when the body’s immune system cannot differentiate between cells that are its own and pathogens. Consequently, the body’s immune system attacks itself causing inflammation ...

UnitedHealth Group is partnering with Eli Lilly to test the efficacy of its COVID-19 monoclonal antibody treatment, bamlanivimab, for patients at high risk of adverse outcomes. Bamlanivimab has not ...

The dominance of the Delta strain of COVID-19 combined with Alabama’s low vaccination rate has led experts to turn to monoclonal antibody infusion, a treatment in which infected individuals are ...

The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...

ARLINGTON, Texas--(BUSINESS WIRE)--AOM Infusion, a leading provider of specialty infusion therapy, announced today that it has been selected by GC Biopharma as a limited distribution partner for ...

We included 692 patients, of whom 6.7% (n = 47) had experienced one or more IRRs (n = 63). The highest incidence of IRRs (n = 50) were found in patients treated with rituximab (incidence IRR 26%), ...